You’ve probably seen this: a seemingly straightforward hypercalcemia question, then the answer choices explode into a minefield of “also causes high calcium” conditions. This is exactly where USMLE-style thinking lives—recognizing the pattern of primary hyperparathyroidism (PHPT), then using labs and physiology to eliminate every distractor with confidence.
Tag: Endocrine > Calcium & Bone Metabolism
The Clinical Vignette (USMLE-Style)
A 56-year-old woman comes to clinic for fatigue and intermittent constipation. She recently passed a kidney stone. She has diffuse bone pain and mild depression. No weight loss or night sweats. Exam is unremarkable.
Labs:
- Calcium: 11.6 mg/dL (high)
- Phosphate: 2.3 mg/dL (low)
- PTH: elevated
- 25-OH vitamin D: normal
- Creatinine: normal
A DEXA scan shows decreased bone density (worst at the distal radius).
Question: What is the most likely diagnosis (or underlying cause)?
The Correct Answer: Primary Hyperparathyroidism
Why it fits
Primary hyperparathyroidism is usually due to a parathyroid adenoma (most common), less often hyperplasia, rarely carcinoma. The hallmark is:
- High calcium
- High (or inappropriately normal) PTH
- Low phosphate
Classic symptoms are the old mnemonic “stones, bones, groans, psychiatric overtones,” but the USMLE expects you to anchor on physiology, not poetry.
Key physiology (what PTH does)
PTH raises serum calcium through three coordinated moves:
- Bone: increases osteoclast activity indirectly by stimulating osteoblasts to express RANKL → osteoclast activation → bone resorption → Ca
- Kidney:
- Ca reabsorption in distal tubule
- phosphate reabsorption in proximal tubule → phosphaturia → low serum phosphate
- Gut (via vitamin D): stimulates renal 1α-hydroxylase → 1,25-(OH) vitamin D → intestinal Ca (and phosphate) absorption
High-yield associated findings
- Nephrolithiasis from hypercalciuria (even though PTH increases distal Ca reabsorption, the filtered load of Ca is high)
- Osteitis fibrosa cystica in severe disease (subperiosteal bone resorption, “brown tumors”)
- Low bone density often most prominent in cortical bone (e.g., distal radius)
The Lab Pattern You Should Memorize
| Condition | Ca | PTH | Phos | 1,25-(OH) D | Key clue |
|---|---|---|---|---|---|
| Primary hyperparathyroidism | (often) | Kidney stones + low phos | |||
| Familial hypocalciuric hypercalcemia (FHH) | /nl | nl/ | nl | Low urine Ca | |
| Humoral hypercalcemia of malignancy (PTHrP) | Cancer, weight loss | ||||
| Vitamin D intoxication | 25-OH D | Supplements, granulomas ddx | |||
| Granulomatous disease (sarcoid, TB) | Macrophages make 1α-hydroxylase | ||||
| Secondary hyperparathyroidism (CKD) | /nl | CKD + high phos | |||
| Tertiary hyperparathyroidism | (often) | variable | Longstanding CKD → autonomous PTH |
Now, Let’s Destroy the Distractors (One by One)
Below are the classic answer choices that show up with this vignette and exactly how to rule them out.
Distractor #1: Familial Hypocalciuric Hypercalcemia (FHH)
Why it’s tempting: It also has high calcium with non-suppressed PTH.
Why it’s wrong here:
- FHH is due to an inactivating mutation in the Ca-sensing receptor (CaSR) (parathyroid + kidney), so the body “thinks” calcium is low.
- The biggest testable differentiator: urinary calcium is low.
High-yield discriminator
- Urine Ca: low in FHH, high/normal in PHPT
- You may be asked for the calcium-to-creatinine clearance ratio (CCCR):
- FHH: typically < 0.01
- PHPT: typically > 0.02
Vignette mismatch: kidney stones and bone disease point more toward PHPT; FHH is often benign/asymptomatic and discovered incidentally.
Distractor #2: Humoral Hypercalcemia of Malignancy (PTHrP)
Why it’s tempting: Hypercalcemia + low phosphate can happen here too.
Why it’s wrong here:
- PTHrP mimics PTH at receptors → Ca, phosphate
- But it suppresses endogenous PTH via negative feedback.
What you should expect
- Ca high
- PTH low
- Often rapid onset symptoms, dehydration, constipation, altered mental status
- Look for malignancy clues: weight loss, smoker, known cancer, etc.
Vignette mismatch: this patient’s PTH is elevated and there’s no malignancy story.
Distractor #3: Multiple Myeloma (Osteolytic Hypercalcemia)
Why it’s tempting: Bone pain + hypercalcemia.
Why it’s wrong here:
- Osteolytic lesions cause hypercalcemia with suppressed PTH.
- Myeloma would usually add: anemia, recurrent infections, renal dysfunction, elevated total protein, rouleaux formation, lytic lesions on imaging.
High-yield clue set
- CRAB: Calcium high, Renal failure, Anemia, Bone lytic lesions
- PTH should be low (unless there’s a second process).
Distractor #4: Vitamin D Intoxication
Why it’s tempting: Hypercalcemia is real, and Step loves supplements.
Why it’s wrong here:
- Vitamin D increases intestinal absorption of both calcium and phosphate, so phosphate tends to be high, not low.
- PTH should be suppressed.
Expected labs
- Ca high
- Phosphate high
- PTH low
- 25-OH vitamin D high (most reflective of intake)
Vignette mismatch: phosphate is low and PTH is high.
Distractor #5: Granulomatous Disease (Sarcoidosis, TB)
Why it’s tempting: Hypercalcemia with normal vitamin D intake.
Why it’s wrong here:
- Activated macrophages express 1α-hydroxylase, converting 25-OH D → 1,25-(OH) D, increasing calcium absorption.
- This suppresses PTH.
Expected labs
- Ca high
- PTH low
- 1,25-(OH) D high
- Often phosphate high (vitamin D increases phosphate absorption)
Vignette mismatch: PTH is elevated, phosphate is low, and there are no pulmonary/systemic granulomatous hints.
Distractor #6: Secondary Hyperparathyroidism (e.g., CKD)
Why it’s tempting: “PTH high” reflexively pushes people here.
Why it’s wrong here:
- In CKD, phosphate retention + low 1,25-(OH) D → hypocalcemia (or low-normal calcium early) → compensatory high PTH.
- Calcium is typically low or normal, not high—unless you’ve progressed to tertiary disease.
Expected labs (CKD secondary HPT)
- Ca low/normal
- Phosphate high
- PTH high
Vignette mismatch: calcium is high and phosphate is low, kidney function is normal.
Distractor #7: Tertiary Hyperparathyroidism
Why it’s tempting: “High PTH + high Ca” can happen.
Why it’s wrong here (usually):
- Tertiary hyperparathyroidism arises after longstanding secondary hyperparathyroidism (classically CKD), where parathyroids become autonomous.
- Phosphate is often high because CKD persists.
Expected context
- History of end-stage renal disease, dialysis, very high PTH, high phosphate.
Vignette mismatch: normal creatinine, low phosphate, no CKD story.
Q-Bank Power Moves (What They’re Really Testing)
1) “Inappropriately high PTH”
Any time calcium is high, PTH should be low. If it’s high or even “normal”, that’s abnormal and narrows the differential to:
- Primary hyperparathyroidism
- FHH
- Lithium therapy (raises the set point of CaSR → can look like PHPT)
2) Phosphate is not decoration
- Low phosphate points toward PTH/PTHrP effect
- High phosphate points toward vitamin D effect or renal failure
3) Bone density pattern can hint PHPT
PHPT preferentially affects cortical bone, so the distal one-third radius may be disproportionately low.
Extra High-Yield Facts (USMLE Favorite Details)
- Most common cause of PHPT: Parathyroid adenoma
- Most common cause of hypercalcemia overall (outpatients): Primary hyperparathyroidism
- Most common cause of hypercalcemia in hospitalized patients: Malignancy
- ECG change with hypercalcemia: shortened QT interval
- Treatment basics (Step-level):
- Symptomatic severe hypercalcemia: IV fluids → calcitonin (quick) → bisphosphonates (sustained)
- Definitive for PHPT when indicated: parathyroidectomy
- MEN associations: PHPT can be part of MEN1 (pituitary, parathyroid, pancreatic tumors)
One-Paragraph Summary (Burn This In)
Primary hyperparathyroidism presents with hypercalcemia, elevated PTH, and low phosphate, often with kidney stones and cortical bone loss. Most distractors that cause hypercalcemia (malignancy, vitamin D excess, granulomatous disease, myeloma) will have suppressed PTH; FHH is the big “PTH not suppressed” mimic, distinguished by low urinary calcium (low CCCR).